GeoVax Labs, Inc. (NASDAQ:GOVXW – Get Free Report) was down 7.2% during trading on Friday . The company traded as low as $0.10 and last traded at $0.10. Approximately 11,526 shares were traded during mid-day trading, a decline of 50% from the average daily volume of 23,197 shares. The stock had previously closed at $0.11.
GeoVax Labs Trading Down 7.2 %
The firm has a fifty day moving average price of $0.15 and a two-hundred day moving average price of $0.13.
GeoVax Labs Company Profile
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.
Featured Articles
- Five stocks we like better than GeoVax Labs
- With Risk Tolerance, One Size Does Not Fit All
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Industrial Products Stocks Investing
- Top-Performing Non-Leveraged ETFs This Year
- What is a SEC Filing?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.com's FREE daily email newsletter.
